JP2024524701A5 - - Google Patents
Info
- Publication number
- JP2024524701A5 JP2024524701A5 JP2024502063A JP2024502063A JP2024524701A5 JP 2024524701 A5 JP2024524701 A5 JP 2024524701A5 JP 2024502063 A JP2024502063 A JP 2024502063A JP 2024502063 A JP2024502063 A JP 2024502063A JP 2024524701 A5 JP2024524701 A5 JP 2024524701A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- crystal
- film
- tablet
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP21186105.9 | 2021-07-16 | ||
| EP21186105 | 2021-07-16 | ||
| EP21199739 | 2021-09-29 | ||
| EP21199739.0 | 2021-09-29 | ||
| PCT/EP2022/070063 WO2023285706A1 (en) | 2021-07-16 | 2022-07-18 | Solid-state forms of 2-(3-(4-(1h-indazol-5-ylamino)quinazolin-2-yl )phenoxy)-n- isopropylacetamide methane sulfonic acid salt |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024524701A JP2024524701A (ja) | 2024-07-05 |
| JP2024524701A5 true JP2024524701A5 (cg-RX-API-DMAC10.html) | 2025-07-28 |
Family
ID=82850759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502063A Pending JP2024524701A (ja) | 2021-07-16 | 2022-07-18 | 2-(3-(4-(1h-インダゾール-5-イルアミノ)キナゾリン-2-イル)フェノキシ)-n-イソプロピルアセトアミドメタンスルホン酸塩の固体形態 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20240343712A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4370205A1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024524701A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2023285706A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL320719A (en) | 2022-11-11 | 2025-07-01 | Assia Chem Ind Ltd | Solid forms of blomosodil and processes for obtaining blomosodil |
| CN117603194A (zh) * | 2023-10-30 | 2024-02-27 | 南京科默生物医药有限公司 | 一种甲磺酸贝舒地尔的晶型及其制备工艺 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR9465A (es) * | 2005-03-25 | 2008-06-19 | Surface Logix Inc | Compuestos mejorados farmacocineticamente |
| CA2700988A1 (en) | 2006-09-27 | 2008-05-08 | Surface Logix, Inc. | Rho kinase inhibitors |
| EA201500364A1 (ru) | 2012-10-05 | 2015-08-31 | Кадмон Корпорейшн, Ллк | Лечение глазных заболеваний |
| RS63503B1 (sr) | 2012-10-05 | 2022-09-30 | Kadmon Corporation Llc | Inhibitori rho kinaze |
| WO2021129589A1 (zh) * | 2019-12-27 | 2021-07-01 | 广东东阳光药业有限公司 | Kd-025的新晶型及其制备方法 |
| EP3875078A1 (en) * | 2020-03-06 | 2021-09-08 | Dompe' Farmaceutici S.P.A. | Compounds for the treatment of covid-19 |
| KR20230043910A (ko) * | 2020-07-22 | 2023-03-31 | 테바 파마슈티컬스 인터내셔널 게엠베하 | 벨루모수딜 및 벨루모수딜 염의 고체 상태 형태 |
| WO2022170864A1 (zh) * | 2021-02-09 | 2022-08-18 | 苏州科睿思制药有限公司 | Belumosudil甲磺酸盐的晶型及其制备方法和用途 |
-
2022
- 2022-07-18 WO PCT/EP2022/070063 patent/WO2023285706A1/en not_active Ceased
- 2022-07-18 US US18/579,041 patent/US20240343712A1/en active Pending
- 2022-07-18 JP JP2024502063A patent/JP2024524701A/ja active Pending
- 2022-07-18 EP EP22753667.9A patent/EP4370205A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6162197B2 (ja) | 即時/遅延ドラッグデリバリー | |
| JP6162196B2 (ja) | 遅延性持続ドラッグデリバリー | |
| JP6165824B2 (ja) | パルス状薬剤放出 | |
| JP7456721B2 (ja) | 5-メチル-1-フェニル-2-(1h)-ピリドンの顆粒製剤及びその製造方法 | |
| JP6043281B2 (ja) | 4−アミノ−5−フルオロ−3−[6−(4−メチルピペラジン−1−イル)−1h−ベンズイミダゾール−2−イル]−1h−キノリン−2−オンラクテート一水和物を含む医薬組成物 | |
| JP2022511029A5 (cg-RX-API-DMAC10.html) | ||
| KR102233757B1 (ko) | 유기 화합물의 제제 | |
| CN106414466A (zh) | 替诺福韦艾拉酚胺复合物及其制备方法和用途 | |
| CN1970547B (zh) | 非布司他的晶型及其制备方法 | |
| JP7665702B2 (ja) | アキシチニブを含有する医薬組成物 | |
| JP2025506374A5 (cg-RX-API-DMAC10.html) | ||
| EP2051694A2 (en) | Pharmaceutical compositions comprising aripiprazole | |
| CN111699190A (zh) | 比卡格韦钠的晶形 | |
| JP2023528896A5 (cg-RX-API-DMAC10.html) | ||
| JP2025527471A5 (cg-RX-API-DMAC10.html) | ||
| TWI910222B (zh) | 為單片基質錠劑形式之控釋型含瑞巴派特醫藥組成物及其製備方法 | |
| TW202602449A (zh) | 2-[(3r)-2-[4-胺基-3-(2-氟-4-苯氧基-苯基)吡唑並[3,4-d]嘧啶-1-基]哌啶-1-羰基]-4-甲基-4[4-(氧雜環丁烷-3-基)哌-1-基]-戊-2-烯腈的調配物 | |
| JP2022097443A (ja) | ビラスチンを含有する口腔内崩壊錠 | |
| EP3217964A1 (en) | Composition | |
| JP2024525954A5 (cg-RX-API-DMAC10.html) | ||
| CN119365195A (zh) | 含有匹米替比的医药组合物 | |
| US10688050B1 (en) | Pharmaceutical composition comprising ibrutinib | |
| JP2024500545A5 (cg-RX-API-DMAC10.html) | ||
| JP7506475B2 (ja) | フェブキソスタット製剤 | |
| WO2022143168A1 (zh) | 含有吡咯喹啉醌三锂盐九水化合物的药物组合物、胶囊剂及其制备方法 |